Tag Archives: HIV

Pharma Alert Q&A: Viread China’s First Victim of Compulsory Licensing?

Innovative pharmaceuticals take notice. Reuters’ Tan Ee Lyn asserts that China “overhauled parts of its intellectual property laws” to allow generics companies to start exploiting patented medicines cheaply. In other words allowing compulsory licensing. Tan mentioned one medicine for HIV … Continue reading

Tagged , , , , , , , , , , , , | Comments Off on Pharma Alert Q&A: Viread China’s First Victim of Compulsory Licensing?